Skip to content

Released Apr 30, 2021, before the open

10-Q filed Apr 30, 2021, 30 days after period end · 0001564590-21-022230

Q1 2021 · 10-Q
Revenue$105.59M+0.7% vs Q1 2020−10.2% vs Q4 2020
Net Income-$5.82MN/M vs Q1 2020N/M vs Q4 2020
EPS Diluted-$0.30N/M vs Q1 2020no prior Q4 2020 on file
Gross Profit$79,679,000−2.1%
Operating Income-$2,916,000N/M
Operating Cash Flow$2,441,000−80.4%
Free Cash Flowderived-$1,924,000N/M
Margins · derived
Gross margin75.5%−2.2 pt vs Q1 2020
Operating margin-2.8%−9.3 pt vs Q1 2020
Net margin-5.5%−30.0 pt vs Q1 2020

What the release said

The release

Same quarter

MetricQ1 2021Q1 2020Q1 2019Q1 2018
Revenue$105.59M$104.82M$109.11M$108.71M
Net Income-$5.82M$25.67M$897.00K$5.23M
EPS Diluted-$0.30$1.32$0.05$0.27

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Orthofix Medical Inc. · CIK 884624 · Engraved from SEC EDGAR